Satomaa, T.; Pynnönen, H.; Vilkman, A.; Kotiranta, T.; Pitkänen, V.; Heiskanen, A.; Herpers, B.; Price, L.S.; Helin, J.; Saarinen, J.
Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility. Antibodies 2018, 7, 15.
https://doi.org/10.3390/antib7020015
AMA Style
Satomaa T, Pynnönen H, Vilkman A, Kotiranta T, Pitkänen V, Heiskanen A, Herpers B, Price LS, Helin J, Saarinen J.
Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility. Antibodies. 2018; 7(2):15.
https://doi.org/10.3390/antib7020015
Chicago/Turabian Style
Satomaa, Tero, Henna Pynnönen, Anja Vilkman, Titta Kotiranta, Virve Pitkänen, Annamari Heiskanen, Bram Herpers, Leo S. Price, Jari Helin, and Juhani Saarinen.
2018. "Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility" Antibodies 7, no. 2: 15.
https://doi.org/10.3390/antib7020015
APA Style
Satomaa, T., Pynnönen, H., Vilkman, A., Kotiranta, T., Pitkänen, V., Heiskanen, A., Herpers, B., Price, L. S., Helin, J., & Saarinen, J.
(2018). Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility. Antibodies, 7(2), 15.
https://doi.org/10.3390/antib7020015